论文部分内容阅读
目的浅析对于新生儿呼吸衰竭的治疗应用新型鼻塞持续气道正压呼吸临床治疗治疗效果,对其治疗效果进行评价并分析其安全性。方法采取本院在2014年至2016年收治的100例新生儿呼吸衰竭病人为观察对象,将其随机划分成研究组以及参照组,每组各50例。为参照组病人提供水封瓶持续气道正压呼吸治疗,研究组给予新型鼻塞持续气道正压呼吸治疗,观察两组病人的治疗效果。结果在治疗后通过对比两组病人的治疗效果发现,研究组的治疗有效率显著高于参照组,对比差异具有统计学意义(P<0.05)。结论采用新型鼻塞持续气道正压呼吸治疗应用于新生儿呼吸衰竭病人的治疗中,其治疗效果良好,安全可靠,值得在临床上推广应用。
Objective To analyze the therapeutic effect of the new type of nasal continuous positive airway pressure breath therapy for the treatment of respiratory failure in neonates and to evaluate its therapeutic effect and analyze its safety. Methods 100 cases of neonatal respiratory failure patients treated in our hospital from 2014 to 2016 were randomly divided into study group and reference group, 50 cases in each group. The patients in the reference group were treated with continuous waterway positive airway pressure breath therapy. The study group was given a new type of nasal continuous positive airway pressure therapy, and the therapeutic effect was observed in both groups. Results After treatment, we found that the treatment efficiency of the study group was significantly higher than that of the reference group (P <0.05) by comparing the treatment effect of the two groups of patients. Conclusion The new type of nasal continuous positive airway pressure therapy for respiratory failure patients with neonatal treatment, the treatment effect is good, safe and reliable, it is worth in the clinical application.